CRISPR Therapeutics (CRSPN.MX) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-45.32
-33.22
-21.13
-9.04

Details

Expected EPS
-23.2423017555
Actual EPS
-21.503547
Surprise EPS
1.74
Surprise Percent
+7.48%

Description

CRISPR Therapeutics (CRSPN.MX) has reported earnings of -21.503547 per share for Q4 2025.

0 Comments

Share your thoughts